Literature DB >> 12424694

Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis.

James R Lokensgard1, Maxim C-J Cheeran, Shuxian Hu, Genya Gekker, Phillip K Peterson.   

Abstract

Glial cells can respond to herpesvirus infections through the production of cytokines and chemokines. Although specific interactions between resident glia and lymphocytes that infiltrate the infected brain remain to be defined, the presence of T cell chemotactic signals in microglial cell supernatants following infection with cytomegalovirus or herpes simplex virus has led to the concept that chemokines initiate a cascade of neuroimmune responses that result in defense of the brain against herpesviruses. While chemokines may play a defensive role by attracting T cells into the brain, aberrant accumulation of lymphocytes may also induce brain damage. Host defense mechanisms must balance control of herpesvirus spread with associated undesirable immunopathologic effects. A growing body of evidence suggests that through complex networks of chemokines and cytokines produced in response to herpesvirus infection, glial cells orchestrate a cascade of events that result in successful defense of or damage to the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424694     DOI: 10.1086/344272

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

2.  Viral induction of central nervous system innate immune responses.

Authors:  J D Rempel; L A Quina; P K Blakely-Gonzales; M J Buchmeier; D L Gruol
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 3.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.

Authors:  W Hans Meisen; Eric S Wohleb; Alena Cristina Jaime-Ramirez; Chelsea Bolyard; Ji Young Yoo; Luke Russell; Jayson Hardcastle; Samuel Dubin; Kamaldeen Muili; Jianhua Yu; Michael Caligiuri; Jonathan Godbout; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2015-03-31       Impact factor: 12.531

5.  Differential responses of human brain cells to West Nile virus infection.

Authors:  Maxim C-J Cheeran; Shuxian Hu; Wen S Sheng; Ayesha Rashid; Phillip K Peterson; James R Lokensgard
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

Review 6.  Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model.

Authors:  Irena Slavuljica; Daria Kveštak; Peter Csaba Huszthy; Kate Kosmac; William J Britt; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2014-07-21       Impact factor: 11.530

7.  An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.

Authors:  Olus Uyar; Nataly Laflamme; Jocelyne Piret; Marie-Christine Venable; Julie Carbonneau; Karima Zarrouk; Serge Rivest; Guy Boivin
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

Review 8.  Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.

Authors:  Hui Liu; Ke Qiu; Qiang He; Qiang Lei; Wei Lu
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-19       Impact factor: 4.147

9.  The immune response to herpes simplex virus encephalitis in mice is modulated by dietary vitamin E.

Authors:  Patricia A Sheridan; Melinda A Beck
Journal:  J Nutr       Date:  2008-01       Impact factor: 4.798

10.  Intracerebral infection with murine cytomegalovirus induces CXCL10 and is restricted by adoptive transfer of splenocytes.

Authors:  Maxim C-J Cheeran; Genya Gekker; Shuxian Hu; Xinan Min; Diana Cox; James R Lokensgard
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.